SIP
AMPE

Stoneridge Investment Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Stoneridge Investment Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-177
Closed -$188K – 286
2014
Q3 		$188K Buy
+177
New +$298K 0.03% 226

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stoneridge Investment Partners's AMPE Position: Q4 2014 in Review

Stoneridge Investment Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2014, closing a stake of 177 shares — an estimated $188K sold.

Stoneridge Investment Partners first reported a position in AMPE in Q3 2014 and held it in 1 quarter. The position peaked at $188K in Q3 2014. 69 funds tracked by Wall St. Rank hold AMPE as of Q4 2014.

  • Stoneridge Investment Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • Stoneridge Investment Partners sold 177 Ampio Pharmaceuticals Inc. shares in Q4 2014, an estimated $188K.
  • Stoneridge Investment Partners first reported a position in Ampio Pharmaceuticals Inc. in Q3 2014 and held it in 1 quarter.
  • Stoneridge Investment Partners's Ampio Pharmaceuticals Inc. position peaked at $188K in Q3 2014.
  • 69 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2014.

Based on Stoneridge Investment Partners's 13F filing for Q4 2014, filed 26 Jan 2015.